|
1
|
Asahara T, Murohara T, Sullivan A, Silver
M, van der Zee R, Li T, Witzenbichler B, Schatteman G and Isner JM:
Isolation of putative progenitor endothelial cells for
angiogenesis. Science. 275:964–967. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Peichev M, Naiyer AJ, Pereira D, Zhu Z,
Lane WJ, Williams M, Oz MC, Hicklin DJ, Witte L, Moore MA, et al:
Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells
identifies a population of functional endothelial precursors.
Blood. 95:952–958. 2000.PubMed/NCBI
|
|
3
|
Urbich C, Aicher A, Heeschen C, Dernbach
E, Hofmann WK, Zeiher AM and Dimmeler S: Soluble factors released
by endothelial progenitor cells promote migration of endothelial
cells and cardiac resident progenitor cells. J Mol Cell Cardiol.
39:733–742. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kamihata H, Matsubara H, Nishiue T,
Fujiyama S, Tsutsumi Y, Ozono R, Masaki H, Mori Y, Iba O, Tateishi
E, et al: Implantation of bone marrow mononuclear cells into
ischemic myocardium enhances collateral perfusion and regional
function via side supply of angioblasts, angiogenic ligands, and
cytokines. Circulation. 104:1046–1052. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Asahara T, Kawamoto A and Masuda H:
Concise review: Circulating endothelial progenitor cells for
vascular medicine. Stem Cells. 29:1650–1655. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shi Q, Rafii S, Wu MH, Wijelath ES, Yu C,
Ishida A, Fujita Y, Kothari S, Mohle R, Sauvage LR, et al: Evidence
for circulating bone marrow-derived endothelial cells. Blood.
92:362–367. 1998.PubMed/NCBI
|
|
7
|
Asahara T, Masuda H, Takahashi T, Kalka C,
Pastore C, Silver M, Kearne M, Magner M and Isner JM: Bone marrow
origin of endothelial progenitor cells responsible for postnatal
vasculogenesis in physiological and pathological
neovascularization. Circ Res. 85:221–228. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Takahashi T, Kalka C, Masuda H, Chen D,
Silver M, Kearney M, Magner M, Isner JM and Asahara T: Ischemia-and
cytokine-induced mobilization of bone marrow-derived endothelial
progenitor cells for neovascularization. Nat Med. 5:434–438. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Asahara T, Takahashi T, Masuda H, Kalka C,
Chen D, Iwaguro H, Inai Y, Silver M and Isner JM: VEGF contributes
to postnatal neovascularization by mobilizing bone marrow-derived
endothelial progenitor cells. EMBO J. 18:3964–3972. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li WD and Li XQ: Endothelial progenitor
cells accelerate the resolution of deep vein thrombosis. Vascul
Pharmacol. 83:10–16. 2016. View Article : Google Scholar
|
|
11
|
Wang W, Li C, Li W, Kong L, Qian A, Hu N,
Meng Q and Li X: MiR-150 enhances the motility of EPCs in vitro and
promotes EPCs homing and thrombus resolving in vivo. Thromb Res.
133:590–598. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Alessio AM, Beltrame MP, Nascimento MC,
Vicente CP, de Godoy JA, Silva JC, Bittar LF, Lorand-Metze I, de
Paula EV and Annichino-Bizzacchi JM: Circulating progenitor and
mature endothelial cells in deep vein thrombosis. Int J Med Sci.
10:1746–1754. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nuzzolo ER, Iachininoto MG and Teofili L:
Endothelial progenitor cells and thrombosis. Thromb Res.
129:309–313. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ingram DA, Lien IZ, Mead LE, Estes M,
Prater DN, Derr-Yellin E, DiMeglio LA and Haneline LS: In vitro
hyperglycemia or a diabetic intrauterine environment reduces
neonatal endothelial colony-forming cell numbers and function.
Diabetes. 57:724–731. 2008. View Article : Google Scholar
|
|
15
|
Michaud SE, Dussault S, Haddad P, Groleau
J and Rivard A: Circulating endothelial progenitor cells from
healthy smokers exhibit impaired functional activities.
Atherosclerosis. 187:423–432. 2006. View Article : Google Scholar
|
|
16
|
Vasa M, Fichtlscherer S, Aicher A, Adler
K, Urbich C, Martin H, Zeiher AM and Dimmeler S: Number and
migratory activity of circulating endothelial progenitor cells
inversely correlate with risk factors for coronary artery disease.
Circ Res. 89:E1–E7. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Menegazzo L, Albiero M, Avogaro A and
Fadini GP: Endothelial progenitor cells in diabetes mellitus.
Biofactors. 38:194–202. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fadini GP, Miorin M, Facco M, Bonamico S,
Baesso I, Grego F, Menegolo M, de Kreutzenberg SV, Tiengo A,
Agostini C, et al: Circulating endothelial progenitor cells are
reduced in peripheral vascular complications of type 2 diabetes
mellitus. J Am Coll Cardiol. 45:1449–1457. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhou G, Myers R, Li Y, Chen Y, Shen X,
Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, et al: Role of
AMP-activated protein kinase in mechanism of metformin action. J
Clin Invest. 108:1167–1174. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Inzucchi SE, Lipska KJ, Mayo H, Bailey CJ
and McGuire DK: Metformin in patients with type 2 diabetes and
kidney disease: A systematic review. JAMA. 312:2668–2675. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mather KJ, Verma S and Anderson TJ:
Improved endothelial function with metformin in type 2 diabetes
mellitus. J Am Coll Cardiol. 37:1344–1350. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Desouza CV: Does drug therapy reverse
endothelial progenitor cell dysfunction in diabetes? J Diabetes
Complications. 27:519–525. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li WD, Du XL, Qian AM, Hu N, Kong LS, Wei
S, Li CL and Li XQ: Metformin regulates differentiation of bone
marrow-derived endothelial progenitor cells via multiple
mechanisms. Biochem Biophys Res Commun. 465:803–809. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ingram DA, Mead LE, Tanaka H, Meade V,
Fenoglio A, Mortell K, Pollok K, Ferkowicz MJ, Gilley D and Yoder
MC: Identification of a novel hierarchy of endothelial progenitor
cells using human peripheral and umbilical cord blood. Blood.
104:2752–2760. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Rehman J, Li J, Orschell CM and March KL:
Peripheral blood 'endothelial progenitor cells' are derived from
monocyte/macrophages and secrete angiogenic growth factors.
Circulation. 107:1164–1169. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kalka C, Masuda H, Takahashi T, Kalka-Moll
WM, Silver M, Kearney M, Li T, Isner JM and Asahara T:
Transplantation of ex vivo expanded endothelial progenitor cells
for therapeutic neovascularization. Proc Natl Acad Sci USA.
97:3422–3427. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
James MF, Beauchamp RL, Manchanda N,
Kazlauskas A and Ramesh V: A NHERF binding site links the betaPDGFR
to the cytoskeleton and regulates cell spreading and migration. J
Cell Sci. 117:2951–2961. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li WD, Hu N, Lei FR, Wei S, Rong JJ,
Zhuang H and Li XQ: Autophagy inhibits endothelial progenitor cells
migration via the regulation of MMP-2, MMP-9 and uPA under normoxia
condition. Biochem Biophys Res Commun. 466:376–380. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ji Y, Strawn TL, Grunz EA, Stevenson MJ,
Lohman AW, Lawrence DA and Fay WP: Multifaceted role of plasminogen
activator inhibitor-1 in regulating early remodeling of vein bypass
grafts. Arterioscler Thromb Vasc Biol. 31:1781–1787. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Oku N, Sasabe E, Ueta E, Yamamoto T and
Osaki T: Tight junction protein claudin-1 enhances the invasive
activity of oral squamous cell carcinoma cells by promoting
cleavage of laminin-5 gamma2 chain via matrix metalloproteinase
(MMP)-2 and membrane-type MMP-1. Cancer Res. 66:5251–5257. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li W, Tanaka K, Chiba Y, Kimura T, Morioka
K, Uesaka T, Ihaya A, Sasaki M, Tsuda T and Yamada N: Role of MMPs
and plasminogen activators in angiogenesis after transmyocardial
laser revascularization in dogs. Am J Physiol Heart Circ Physiol.
284:H23–H30. 2003. View Article : Google Scholar
|
|
32
|
Xu S, Zhu J, Yu L and Fu G: Endothelial
progenitor cells: Current development of their paracrine factors in
cardiovascular therapy. J Cardiovasc Pharmacol. 59:387–396. 2012.
View Article : Google Scholar
|
|
33
|
Resch T, Pircher A, Kähler CM, Pratschke J
and Hilbe W: Endothelial progenitor cells: Current issues on
characterization and challenging clinical applications. Stem Cell
Rev. 8:926–939. 2012. View Article : Google Scholar
|
|
34
|
Loomans CJ, de Koning EJ, Staal FJ,
Rookmaaker MB, Verseyden C, de Boer HC, Verhaar MC, Braam B,
Rabelink TJ and van Zonneveld AJ: Endothelial progenitor cell
dysfunction: A novel concept in the pathogenesis of vascular
complications of type 1 diabetes. Diabetes. 53:195–199. 2004.
View Article : Google Scholar
|
|
35
|
Barthelmes D, Irhimeh MR, Gillies MC,
Karimipour M, Zhou M, Zhu L and Shen WY: Diabetes impairs
mobilization of mouse bone marrow-derived Lin(−)/VEGF-R2(+)
progenitor cells. Blood Cells Mol Dis. 51:163–173. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chen LL, Liao YF, Zeng TS, Yu F, Li HQ and
Feng Y: Effects of metformin plus gliclazide compared with
metformin alone on circulating endothelial progenitor cell in type
2 diabetic patients. Endocrine. 38:266–275. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Esposito K, Maiorino MI, Di Palo C,
Gicchino M, Petrizzo M, Bellastella G, Saccomanno F and Giugliano
D: Effects of pioglitazone versus metformin on circulating
endothelial microparticles and progenitor cells in patients with
newly diagnosed type 2 diabetes - a randomized controlled trial.
Diabetes Obes Metab. 13:439–445. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li X, Han Y, Pang W, Li C, Xie X, Shyy JY
and Zhu Y: AMP-activated protein kinase promotes the
differentiation of endothelial progenitor cells. Arterioscler
Thromb Vasc Biol. 28:1789–1795. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yan Y, Tsukamoto O, Nakano A, Kato H,
Kioka H, Ito N, Higo S, Yamazaki S, Shintani Y, Matsuoka K, et al:
Augmented AMPK activity inhibits cell migration by phosphorylating
the novel substrate Pdlim5. Nat Commun. 6:61372015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Park SY, Jung CH, Song B, Park OJ and Kim
YM: Pro-apoptotic and migration-suppressing potential of EGCG, and
the involvement of AMPK in the p53-mediated modulation of VEGF and
MMP-9 expression. Oncol Lett. 6:1346–1350. 2013.PubMed/NCBI
|
|
41
|
Lee GR, Jang SH, Kim CJ, Kim AR, Yoon DJ,
Park NH and Han IS: Capsaicin suppresses the migration of
cholangiocarcinoma cells by downregulating matrix
metalloproteinase-9 expression via the AMPK-NF-κB signaling
pathway. Clin Exp Metastasis. 31:897–907. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Visse R and Nagase H: Matrix
metalloproteinases and tissue inhibitors of metalloproteinases:
Structure, function, and biochemistry. Circ Res. 92:827–839. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Esfahanian N, Shakiba Y, Nikbin B, Soraya
H, Maleki-Dizaji N, Ghazi-Khansari M and Garjani A: Effect of
metformin on the proliferation, migration, and MMP-2 and -9
expression of human umbilical vein endothelial cells. Mol Med Rep.
5:1068–1074. 2012.PubMed/NCBI
|
|
44
|
Hwang YP and Jeong HG: Metformin blocks
migration and invasion of tumour cells by inhibition of matrix
metalloproteinase-9 activation through a calcium and protein kinase
Calpha-dependent pathway:
Phorbol-12-myristate-13-acetate-induced/extracellular
signal-regulated kinase/activator protein-1. Br J Pharmacol.
160:1195–1211. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Fang Z, Xu X, Zhou Z, Xu Z and Liu Z:
Effect of metformin on apoptosis, cell cycle arrest migration and
invasion of A498 cells. Mol Med Rep. 9:2251–2256. 2014.PubMed/NCBI
|
|
46
|
Yang N, Hui L, Wang Y, Yang H and Jiang X:
SOX2 promotes the migration and invasion of laryngeal cancer cells
by induction of MMP-2 via the PI3K/Akt/mTOR pathway. Oncol Rep.
31:2651–2659. 2014.PubMed/NCBI
|
|
47
|
Chen JS, Wang Q, Fu XH, Huang XH, Chen XL,
Cao LQ, Chen LZ, Tan HX, Li W, Bi J, et al: Involvement of
PI3K/PTEN/AKT/mTOR pathway in invasion and metastasis in
hepatocellular carcinoma: Association with MMP-9. Hepatol Res.
39:177–186. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Tomic T, Botton T, Cerezo M, Robert G,
Luciano F, Puissant A, Gounon P, Allegra M, Bertolotto C, Bereder
JM, et al: Metformin inhibits melanoma development through
autophagy and apoptosis mechanisms. Cell Death Dis. 2:e1992011.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Kim YC and Guan KL: mTOR: A pharmacologic
target for autophagy regulation. J Clin Invest. 125:25–32. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Zhan Z, Xie X, Cao H, Zhou X, Zhang XD,
Fan H and Liu Z: Autophagy facilitates TLR4- and TLR3-triggered
migration and invasion of lung cancer cells through the promotion
of TRAF6 ubiquitination. Autophagy. 10:257–268. 2014. View Article : Google Scholar
|
|
51
|
Tuloup-Minguez V, Hamaï A, Greffard A,
Nicolas V, Codogno P and Botti J: Autophagy modulates cell
migration and β1 integrin membrane recycling. Cell Cycle.
12:3317–3328. 2013. View Article : Google Scholar : PubMed/NCBI
|
